Antagonist Functional Selectivity: 5-HT2A Serotonin Receptor Antagonists Differentially Regulate 5-HT2A Receptor Protein Level In Vivo
- 7 July 2011
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in The Journal of pharmacology and experimental therapeutics
- Vol. 339 (1), 99-105
- https://doi.org/10.1124/jpet.111.183780
Abstract
Dysregulation of the 5-HT2A receptor is implicated in both the etiology and treatment of schizophrenia. Although the essential role of 5-HT2A receptors in atypical antipsychotic drug actions is widely accepted, the contribution of 5-HT2A down-regulation to their efficacy is not known. We hypothesized that down-regulation of cortical 5-HT2A receptors contributes to the therapeutic action of atypical antipsychotic drugs. To test this hypothesis, we assessed the effect of chronically administered antipsychotics (clozapine, olanzapine, and haloperidol) and several 5-HT2A antagonists [ketanserin, altanserin, α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidinemethanol (M100907), α-phenyl-1-(2-phenylethyl)-4-piperidinemethano (M11939), 4-[(2Z)-3-{[2-(dimethylamino)ethoxy]amino}-3-(2-fluorophenyl)prop-2-en-1-ylidene]cyclohexa-2,5-dien-1-one (SR46349B), and pimavanserin], on the phencyclidine (PCP)-induced hyperlocomotor response and cortical 5-HT2A receptor levels in C57BL/6J mice. Clozapine and olanzapine, but not haloperidol, induced receptor down-regulation and attenuated PCP-induced locomotor responses. Of the selective 5-HT2A antagonists tested, only ketanserin caused significant receptor protein down-regulation, whereas SR46349B up-regulated 5-HT2A receptors and potentiated PCP-hyperlocomotion; the other 5-HT2A receptor antagonists were without effect. The significance of these findings with respect to atypical antipsychotic drug action is discussed.Keywords
This publication has 39 references indexed in Scilit:
- The Role of 5-Hydroxytryptamine 7 Receptors in the Phencyclidine-Induced Novel Object Recognition Deficit in RatsThe Journal of pharmacology and experimental therapeutics, 2011
- The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptorNature, 2011
- Structure and function of an irreversible agonist-β2 adrenoceptor complexNature, 2011
- The Presynaptic Component of the Serotonergic System is Required for Clozapine's EfficacyNeuropsychopharmacology, 2010
- CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signalingNature Neuroscience, 2010
- Pimavanserin, a Serotonin(2A) Receptor Inverse Agonist, for the Treatment of Parkinson's Disease PsychosisNeuropsychopharmacology, 2010
- Htr2a gene and 5-HT2A receptor expression in the cerebral cortex studied using genetically modified miceFrontiers in Neuroscience, 2010
- PSD-95 Is Essential for Hallucinogen and Atypical Antipsychotic Drug Actions at Serotonin ReceptorsJournal of Neuroscience, 2009
- Chronic mianserin treatment decreases 5-HT2 receptor binding without altering 5-HT2 receptor mRNA levelsEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Multiple mechanisms of serotonergic signal transductionLife Sciences, 1987